NASDAQ$MASS

908 Devices Inc · Q1 2024 earnings

Q1 2024 earnings · · Investor relations

Briefing

908 Devices reported a revenue increase of 5% driven by handheld device sales and acquired RedWave Technology to expand its forensics product portfolio.

908 Devices reported a solid start to 2024 with a 5% increase in revenue to $10 million. The acquisition of RedWave Technology is expected to bolster their forensics product offerings.

  • Revenue increased by 5% year-over-year, reaching $10.0 million.
  • Handheld device revenue increased, offsetting a decrease in desktop device revenue.
  • Gross profit increased to $5.0 million, with a gross margin of 50%.
  • Net loss decreased to $10.9 million, or $0.33 per share.

Headline financials

Total Revenue

$9.99M

Previous: $9.49M+5.3%
EPS

-$0.33

Previous: -$0.39+15.4%
Installed Base

2.5K

No prior period
Recurring Revenue %

2857143.0%

Previous: 4200000.0%-32.0%
Capital Expenditures

-$903K

Previous: -$1.19M+23.8%
Free Cash Flow

-$11.8M

Previous: -$13.7M+13.8%
Net Income

-$10.9M

Previous: -$12.5M+12.9%
Operating Income

-$12.7M

Previous: -$13M+2.5%
Gross Profit

$5M

Previous: $4.38M+14.1%
R&D Expense

$5.79M

No prior period
Stock-Based Comp

$2.64M

Previous: $2.17M+22.0%

Revenue & EPS history

908 Devices · Revenue · Quarterly

$9.99M

Q1 2024+5.3%vs Q1 2023
Beat estimate in 12 of 15 quarters(80%)
ActualEstimate

Forward guidance

908 Devices anticipates full year 2024 revenue to be in the range of $63.0 million to $65.0 million, representing 25% to 29% growth over 2023, including $11 million from RedWave Technology.

Tailwinds

  • Full year revenue expected to grow 25% to 29% compared to 2023.
  • RedWave Technology acquisition expected to contribute $11 million in revenue.
  • Cash on hand is expected to be sufficient to reach cash flow breakeven.
  • Increased demand for handheld devices.
  • Expansion of forensics product portfolio.

Headwinds

  • No specific negatives were mentioned in the provided text.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q1 2024

Historical avgQ1 2024

+1.3%

Avg return

Earnings day

-2.9%

Avg return

5 days after

+2.8%

Avg return

30 days after

46%

11 / 24 earnings

Positive

+96.0%

Q4 2024

Best reaction

-35.4%

Q3 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026+13.7%+11.8%+11.8%
Q4 2025-4.8%-5.3%+0.0%
Q3 2025-13.2%-25.7%-10.8%
Q1 2025-18.9%-20.1%+25.5%
Q4 2024+96.0%+39.4%+88.9%
Q3 2024-35.4%-34.0%-41.4%
Q2 2024-5.0%-6.0%-21.6%
Q1 2024-1.4%-1.8%+7.0%
Q4 2023-1.1%-5.1%-10.1%
Q3 2023-4.9%-11.2%+23.0%
Q2 2023+17.7%+15.0%+8.1%
Q1 2023+8.4%+4.8%+28.6%
Q4 2022+0.3%-10.6%-5.5%
Q3 2022-34.4%-38.2%-44.4%
Q2 2022-8.9%-9.9%-7.6%
Q1 2022-12.6%+6.6%-5.5%
Q4 2021+12.8%+17.2%+24.7%
Q3 2021+14.7%+2.7%-30.0%
Q3 2020+14.7%+2.7%-30.0%
Q2 2021+9.4%+5.4%+26.2%
Q2 2020+9.4%+5.4%+26.2%
Q1 2021-16.3%-14.6%-7.3%
Q1 2020-16.3%-14.6%-7.3%
Q4 2020+7.8%+15.8%+18.0%
Q4 2019
Q3 2019
Q2 2019
Q1 2019

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro